CRYSTAL PALMER: Open Payments
NPI 1366632010 · PLATTSBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,058 in 104 payments from 17 companies in 2025. Trend: 2023 $1,589 · 2024 $1,796 · 2025 $2,058
Food & beverage: $2,058
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $475 |
| Novo Nordisk Inc | 15 | $288 |
| Amgen Inc. | 16 | $215 |
| AstraZeneca Pharmaceuticals LP | 10 | $196 |
| Lilly USA, LLC | 8 | $186 |
| GlaxoSmithKline, LLC. | 7 | $142 |
| PFIZER INC. | 7 | $134 |
| Lundbeck LLC | 6 | $114 |
| Otsuka America Pharmaceutical, Inc. | 5 | $93 |
| Viatris Specialty LLC | 2 | $43 |
Products named: QULIPTA, REXULTI, MOUNJARO, UBRELVY, Ozempic, SHINGRIX, NURTEC ODT, KRYSTEXXA.
Industry payments across NY — which companies pay providers there.
